SmartLabs’ Post

View organization page for SmartLabs, graphic

10,538 followers

Exciting news from, member company, Entrada Therapeutics! We're thrilled to hear about their positive preliminary data from the company’s Phase 1 clinical trial of ENTR-601-44. This breakthrough brings us one step closer to transforming the treatment landscape for Duchenne muscular dystrophy. #Biotech #Duchenne #ClinicalTrials #Infrastructure #Investments #Technology #ClinicalTrials #LifeScience #Pharma #Pharmaceutical #DrugDevelopment #DrugManufacturing #ClinicalData #BusinessDevelopment #Biopharma #DrugDiscovery

See more comments

To view or add a comment, sign in

Explore topics